Is it possible to have infective endocarditis despite negative blood cultures?

Yes, Blood Culture-Negative Endocarditis (BCNE) Absolutely Exists and Accounts for Up to 20% of All Infective Endocarditis Cases

Blood culture-negative infective endocarditis is a well-recognized clinical entity that poses significant diagnostic and therapeutic challenges, with mortality rates that remain concerningly high. 1, 2

Understanding the Scope and Causes

BCNE represents approximately 8-20% of all infective endocarditis cases 2, 3. The three main categories of BCNE are:

1. Prior Antibiotic Exposure (Most Common)

• Patients who received antibiotics before blood cultures were drawn
• This sterilizes blood cultures while active infection persists on valve tissue
• Critical pitfall: Always obtain 3 sets of blood cultures at 30-minute intervals BEFORE starting antibiotics 1

2. Fastidious Organisms

• HACEK group organisms (slow-growing, require extended culture periods)
• Nutritionally variant streptococci
• These can grow with specialized culture techniques and prolonged incubation

3. Intracellular/Non-Culturable Organisms

• Coxiella burnetii (Q fever) - most commonly identified in BCNE 3
• Bartonella species
• Tropheryma whipplei (Whipple's disease)
• Brucella species
• Aspergillus species - causes culture-negative fungal endocarditis, particularly in prosthetic valve endocarditis 4, 1
• Legionella, Mycoplasma - rare causes

Diagnostic Approach for BCNE

When blood cultures remain negative despite clinical suspicion for endocarditis:

Serological Testing (First-Line for Specific Pathogens)

• Coxiella burnetii: Anti-phase I IgG antibody titers 1
• Bartonella species: Specific serology
• Brucella species: Antibody titers 1

Molecular Diagnostics (Increasingly Important)

• 16S rRNA PCR on excised valve tissue - most valuable when surgery is performed 2, 5
• Broad-range PCR identifies: Streptococcus spp, Staphylococcus spp, Propionibacterium spp most commonly 2
• Metagenomic next-generation sequencing - emerging technology showing promise 2
• Specific real-time PCR assays increase diagnostic efficiency 2

Advanced Cardiac Imaging

• PET-CT: Now incorporated into diagnostic criteria for prosthetic valve endocarditis, with usage increasing significantly (12.5% increase) 1, 6
• Cardiac CT: Usage increased 3.1% in recent years 6

Treatment Recommendations

Consultation with an infectious disease specialist from the Endocarditis Team is mandatory for all BCNE cases 4, 1. The empirical antibiotic choice depends on:

Native Valve Endocarditis

• Acute presentation (days): Cover S. aureus, β-hemolytic streptococci, and aerobic Gram-negative bacilli 4
• Subacute presentation (weeks): Cover S. aureus, viridans group streptococci, HACEK organisms, and enterococci 4

Prosthetic Valve Endocarditis

• <1 year post-surgery: Cover staphylococci, enterococci, and aerobic Gram-negative bacilli 4
• >1 year post-surgery: Cover staphylococci, viridans group streptococci, and enterococci 4

Specific Pathogen-Directed Therapy (When Identified)

The 2015 ESC guidelines provide detailed regimens 1:

• Coxiella burnetii: Doxycycline 200 mg/24h + hydroxychloroquine 200-600 mg/24h orally for >18 months
• Bartonella: Doxycycline 100 mg/12h for 4 weeks + gentamicin 3 mg/24h IV for 2 weeks
• Brucella: Doxycycline 200 mg/24h + cotrimoxazole 960 mg/12h + rifampin 300-600 mg/24h for ≥3-6 months
• Aspergillus/fungal IE: Amphotericin B-based therapy + mandatory valve surgery (mortality >50% without surgery) 4, 1

Critical Clinical Pearls

• Surgery is performed MORE frequently in BCNE (57.8% vs 36.9% in culture-positive cases) 3
• In-hospital mortality is NOT significantly different between BCNE and culture-positive endocarditis when appropriately managed 3
• The absence of organism on culture should concern, not reassure clinicians - every effort must be made to identify the pathogen 7
• Over half of patients with IE now undergo early surgery - 16S rRNA PCR of excised valve tissue is vitally important for securing diagnosis 5
• Alternative microbiological diagnosis can be achieved in approximately 47% of BCNE cases when appropriate testing is pursued 3

Major Pitfall to Avoid

The modified Duke criteria remain insensitive to detecting culture-negative infective endocarditis 7. Do not rely solely on Duke criteria when clinical suspicion is high. The absence of positive blood cultures does not exclude endocarditis and should prompt aggressive pursuit of alternative diagnostic methods, particularly serological testing and molecular diagnostics on valve tissue if surgery is performed 7, 5.